She, Y., & Liu, Z. (2022). Effect of Peptide Drug Liraglutide Nano-Formulation Combined with Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients with Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes. Cellular and Molecular Biology, 68(3), 221–228. https://doi.org/10.14715/cmb/2022.68.3.25